MENU
+Compare
COGT
Stock ticker: NASDAQ
AS OF
Aug 1 closing price
Price
$11.40
Change
-$0.02 (-0.18%)
Capitalization
1.59B

COGT Cogent Biosciences Forecast, Technical & Fundamental Analysis

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases... Show more

Industry: #Miscellaneous
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for COGT with price predictions
Aug 01, 2025

COGT sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for COGT moved above the 200-day moving average on July 29, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COGT advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 148 cases where COGT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for COGT moved out of overbought territory on July 29, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on COGT as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for COGT turned negative on July 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COGT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

COGT broke above its upper Bollinger Band on July 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COGT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.368) is normal, around the industry mean (17.448). P/E Ratio (0.000) is within average values for comparable stocks, (58.797). COGT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.618). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (276.708).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COGT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

COGT is expected to report earnings to fall 7.65% to -58 cents per share on August 12

Cogent Biosciences COGT Stock Earnings Reports
Q2'25
Est.
$-0.59
Q1'25
Missed
by $0.05
Q4'24
Est.
$-0.61
Q3'24
Missed
by $0.07
Q2'24
Missed
by $0.03
The last earnings report on May 06 showed earnings per share of -63 cents, missing the estimate of -58 cents. With 1.47M shares outstanding, the current market capitalization sits at 1.59B.
A.I. Advisor
published General Information

General Information

a provider of information solution data services and advertising services in the out-of-home advertising industry, which includes outdoor LCD screens and billboards

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Miscellaneous
Address
275 Wyman Street
Phone
+1 617 945-5576
Employees
164
Web
https://www.cogentbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEMRX33.93N/A
N/A
MFS Emerging Markets Equity R1
BDOIX11.27N/A
N/A
iShares MSCI Total Intl Idx Instl
FCALX12.46N/A
N/A
Fidelity Advisor Climate Action C
GQHIX12.98N/A
N/A
GQG Partners US Quality Value Fund Ins
PXWEX34.27-0.45
-1.30%
Impax Ellevate Global Women's Ldr Inv

COGT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-1.13%
SPHDF - COGT
63%
Loosely correlated
N/A
ATXS - COGT
50%
Loosely correlated
-2.53%
CGON - COGT
49%
Loosely correlated
-1.42%
XNCR - COGT
49%
Loosely correlated
-4.09%
IDYA - COGT
48%
Loosely correlated
-0.33%
More